Medline Industries reported a robust performance for the fourth quarter of 2025, with net sales climbing 15% year-over-year to $7.8 billion. Despite the strong sales figures, the company’s stock fell ...

Medline has issued an urgent medical device recall for 4,300 blood culture kits. The Class II recall went into effect December 24, but FDA issued a recall notice February 9. The recall impacts kits ...

NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, ...

“Medline’s IPO was the largest private equity-backed IPO of all time, the largest healthcare IPO ever and the largest public offering of 2025, having traded up strongly on debut,” Robert Schmidt, ...

Jan 12 (Reuters) - Brokerages began coverage of Medline (MDLN.O), opens new tab with largely bullish ratings on Monday, betting on supply chain strength and brand penetration, following the firm's ...

Medline has struck a series of new and expanded partnerships with health systems in recent months, reinforcing its position as a major supply chain player in both medical-surgical and laboratory ...

Medline CEO Jim Boyle (R) celebrates after ringing the opening bell at Nasdaq Marketsite headquarters on Dec. 17, 2025. Photo by Michael M. Santiago/Getty Images A blockbuster IPO from an ...

Medline Inc. completed a record-setting $6.26B IPO, allocating proceeds primarily to reduce leveraged buyout debt from 2021. MDLN operates globally with $20.6B YTD revenue, stable 10% growth, and ...

Medline completed a highly successful IPO, now trading at a $83 billion valuation, being granted a demanding 39x earnings multiple. Medline generates $25.5 billion in annual revenue, up 10% ...

When the Mills family sold Medline Inc. to private equity in one of the largest leveraged buyouts ever, the $32 billion deal seemed the apotheosis of a Covid economy defined by low interest rates and ...

Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer reviewed Medline, a medical supplies giant that made its market debut Wednesday. He said he'd wait for a pullback to buy the stock after shares ...

Medline shares close 41% above offer price in debut Tariffs pose a challenge for Medline SpaceX, others eye 2026 listing Dec 17 (Reuters) - Medical supply giant Medline's shares rose 41% above their ...